{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:28:35Z","timestamp":1793672915657,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Leipzig"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Texture analysis derived from computed tomography (CT) can provide clinically relevant imaging biomarkers. Node-RADS is a recently proposed classification to categorize lymph nodes in radiological images. The present study sought to investigate the diagnostic abilities of CT texture analysis and Node-RADS to discriminate benign from malignant mediastinal lymph nodes in patients with lung cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety-one patients (<jats:italic>n<\/jats:italic>\u2009=\u200932 females, 35%) with a mean age of 64.8\u2009\u00b1\u200910.8\u2009years were included in this retrospective study. Texture analysis was performed using the free available Mazda software. All lymph nodes were scored accordingly to the Node-RADS classification. All primary tumors and all investigated mediastinal lymph nodes were histopathologically confirmed during clinical workup.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In discrimination analysis, Node-RADS score showed statistically significant differences between N0 and N1-3 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Multiple texture features were different between benign and malignant lymph nodes: S(1,0)AngScMom, S(1,0)SumEntrp, S(1,0)Entropy, S(0,1)SumAverg. Correlation analysis revealed positive associations between the texture features with Node-RADS score: S(4,0)Entropy (<jats:italic>r<\/jats:italic>\u2009=\u20090.72, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), S(3,0) Entropy (<jats:italic>r<\/jats:italic>\u2009=\u20090.72, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), S(2,2)Entropy (<jats:italic>r<\/jats:italic>\u2009=\u20090.72, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Several texture features and Node-RADS derived from CT were associated with the malignancy of mediastinal lymph nodes and might therefore be helpful for discrimination purposes. Both of the two quantitative assessments could be translated and used in clinical routine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-022-00506-x","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:02:41Z","timestamp":1672012961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-706X","authenticated-orcid":false,"given":"Hans-Jonas","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schnarkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Pappisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kerkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Kathrin","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Leonhardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Frille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"506_CR1","doi-asserted-by":"publisher","first-page":"20190948","DOI":"10.1259\/bjr.20190948","volume":"93","author":"W Rogers","year":"2020","unstructured":"Rogers W, Thulasi Seetha S, Refaee TAG, et al. Radiomics: from qualitative to quantitative imaging. Br J Radiol. 2020;93:20190948.","journal-title":"Br J Radiol"},{"key":"506_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1148\/rg.2017170056","volume":"37","author":"MG Lubner","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, et al. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics. 2017;37:1483\u2013503.","journal-title":"Radiographics"},{"key":"506_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2214\/AJR.18.20624","volume":"212","author":"BA Varghese","year":"2019","unstructured":"Varghese BA, Cen SY, Hwang DH, Duddalwar VA. Texture analysis of imaging: what radiologists need to know. AJR Am J Roentgenol. 2019;212:520\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"506_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u20136.","journal-title":"Eur J Cancer"},{"key":"506_CR5","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.","journal-title":"Nat Commun"},{"key":"506_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/ijms18040805","volume":"18","author":"M Incoronato","year":"2017","unstructured":"Incoronato M, Aiello M, Infante T, et al. Radiogenomic analysis of oncological data: a technical survey. Int J Mol Sci. 2017;18:805.","journal-title":"Int J Mol Sci"},{"key":"506_CR7","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2014.512","volume":"111","author":"N Just","year":"2014","unstructured":"Just N. Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer. 2014;111:2205\u201313.","journal-title":"Br J Cancer"},{"key":"506_CR8","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","volume":"31","author":"FHJ Elsholtz","year":"2021","unstructured":"Elsholtz FHJ, Asbach P, Haas M, et al. Introducing the node reporting and data system 1.0 (node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol. 2021;31:6116\u201324.","journal-title":"Eur Radiol"},{"key":"506_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MEG.0000000000001269","volume":"31","author":"M Renzulli","year":"2019","unstructured":"Renzulli M, Clemente A, Brocchi S, et al. LI-RADS: a great opportunity not to be missed. Eur J Gastroenterol Hepatol. 2019;31:283\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"506_CR10","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2214\/AJR.09.3423","volume":"194","author":"CK Bent","year":"2010","unstructured":"Bent CK, Bassett LW, D'Orsi CJ, Sayre JW. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol. 2010;194:1378\u201383.","journal-title":"AJR Am J Roentgenol"},{"key":"506_CR11","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00261-017-1169-5","volume":"42","author":"EJ Jordan","year":"2017","unstructured":"Jordan EJ, Fiske C, Zagoria RJ, Westphalen AC. Evaluating the performance of PI-RADS v2 in the non-academic setting. Abdom Radiol (NY). 2017;42:2725\u201331.","journal-title":"Abdom Radiol (NY)"},{"key":"506_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12902-019-0429-5","volume":"19","author":"TLM Barbosa","year":"2019","unstructured":"Barbosa TLM, Junior COM, Graf H, et al. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology. BMC Endocr Disord. 2019;19:112.","journal-title":"BMC Endocr Disord"},{"key":"506_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.euo.2018.01.002","volume":"1","author":"A Stabile","year":"2018","unstructured":"Stabile A, Dell'Oglio P, De Cobelli F, et al. Association between prostate imaging reporting and data system (PI-RADS) score for the index lesion and multifocal, clinically significant prostate Cancer. Eur Urol Oncol. 2018;1:29\u201336.","journal-title":"Eur Urol Oncol"},{"key":"506_CR14","doi-asserted-by":"publisher","first-page":"e211S","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e211S\u201350S.","journal-title":"Chest"},{"key":"506_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/LBR.0000000000000202","volume":"22","author":"L Fuso","year":"2015","unstructured":"Fuso L, Varone F, Smargiassi A, et al. Usefulness of conventional Transbronchial needle aspiration for sampling of Mediastinal lymph nodes in lung Cancer. J Bronchology Interv Pulmonol. 2015;22:294\u20139.","journal-title":"J Bronchology Interv Pulmonol"},{"key":"506_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/1817-1737.78427","volume":"6","author":"E Kupeli","year":"2011","unstructured":"Kupeli E, Memis L, Ozdemirel TS, et al. Transbronchial needle aspiration \"by the books\". Ann Thorac Med. 2011;6:85\u201390.","journal-title":"Ann Thorac Med"},{"key":"506_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jtcvs.2011.08.037","volume":"142","author":"K Yasufuku","year":"2011","unstructured":"Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142:1393\u20131400.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"506_CR18","doi-asserted-by":"publisher","first-page":"e0243181","DOI":"10.1371\/journal.pone.0243181","volume":"15","author":"E Koda","year":"2020","unstructured":"Koda E, Yamashiro T, Onoe R, et al. CT texture analysis of mediastinal lymphadenopathy: combining with US-based elastographic parameter and discrimination between sarcoidosis and lymph node metastasis from small cell lung cancer. PLoS One. 2020;15:e0243181.","journal-title":"PLoS One"},{"key":"506_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40644-019-0214-8","volume":"19","author":"SY Shin","year":"2019","unstructured":"Shin SY, Hong IK, Jo YS. Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes? Cancer Imaging. 2019;19:25.","journal-title":"Cancer Imaging"},{"key":"506_CR20","doi-asserted-by":"publisher","first-page":"43209","DOI":"10.1038\/srep43209","volume":"7","author":"TD Pham","year":"2017","unstructured":"Pham TD, Watanabe Y, Higuchi M, Suzuki H. Texture analysis and synthesis of malignant and benign Mediastinal lymph nodes in patients with lung Cancer on computed tomography. Sci Rep. 2017;7:43209.","journal-title":"Sci Rep"},{"key":"506_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/0284185115598808","volume":"57","author":"MB Andersen","year":"2016","unstructured":"Andersen MB, Harders SW, Ganeshan B, et al. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol. 2016;57:669\u201376.","journal-title":"Acta Radiol"},{"key":"506_CR22","doi-asserted-by":"publisher","first-page":"103119","DOI":"10.1016\/j.critrevonc.2020.103119","volume":"156","author":"G Lamberti","year":"2020","unstructured":"Lamberti G, Andrini E, Sisi M, et al. Beyond EGFR, ALK and ROS1: current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma. Crit Rev Oncol Hematol. 2020;156:103119.","journal-title":"Crit Rev Oncol Hematol"},{"key":"506_CR23","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/cancers14061404","volume":"14","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Cusmai A, Giovannelli F, et al. Impact of proton pump inhibitors and Histamine-2-receptor antagonists on non-small cell lung Cancer immunotherapy: a systematic review and Meta-analysis. Cancers (Basel). 2022;14:1404.","journal-title":"Cancers (Basel)"},{"key":"506_CR24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/CAD.0000000000001118","volume":"32","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Dall'Olio FG, Altimari A, et al. Role of PD-L1 assessment in advanced NSCLC: does it still matter? Anti-Cancer Drugs. 2021;32:1084\u20135.","journal-title":"Anti-Cancer Drugs"},{"key":"506_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1378\/chest.08-0978","volume":"136","author":"FC Detterbeck","year":"2009","unstructured":"Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260\u201371.","journal-title":"Chest"},{"key":"506_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nima.2012.09.006","volume":"702","author":"M Strzelecki","year":"2013","unstructured":"Strzelecki M, Szczypinski P, Materka A, Klepaczko A. A software tool for automatic classification and segmentation of 2D\/3D medical images. Nucl Instrum Methods Phys Res A. 2013;702:137\u201340.","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"506_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmpb.2008.08.005","volume":"94","author":"PM Szczypi\u0144ski","year":"2009","unstructured":"Szczypi\u0144ski PM, Strzelecki M, Materka A, Klepaczko A. MaZda\u2014a software package for image texture analysis. Comput Methods Prog Biomed. 2009;94:66\u201376.","journal-title":"Comput Methods Prog Biomed"},{"key":"506_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/nbm.2962","volume":"26","author":"J Fruehwald-Pallamar","year":"2013","unstructured":"Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L, et al. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 tesla. NMR Biomed. 2013;26:1372\u20139.","journal-title":"NMR Biomed"},{"key":"506_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.tranon.2017.09.003","volume":"10","author":"HJ Meyer","year":"2017","unstructured":"Meyer HJ, Schob S, H\u00f6hn AK, Surov A. MRI texture analysis reflects histopathology parameters in thyroid Cancer - a first preliminary study. Transl Oncol. 2017;10:911\u20136.","journal-title":"Transl Oncol"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.3390\/jcm10235571","volume":"10","author":"HJ Meyer","year":"2021","unstructured":"Meyer HJ, Leonhardi J, H\u00f6hn AK, et al. CT texture analysis of pulmonary neuroendocrine tumors-associations with tumor grading and proliferation. J Clin Med. 2021;10:5571.","journal-title":"J Clin Med"},{"key":"506_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fonc.2019.00444","volume":"9","author":"HJ Meyer","year":"2019","unstructured":"Meyer HJ, Hamerla G, H\u00f6hn AK, Surov A. CT texture analysis-correlations with histopathology parameters in head and neck squamous cell carcinomas. Front Oncol. 2019;9:444.","journal-title":"Front Oncol"},{"key":"506_CR32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19:1180\u201391.","journal-title":"Lancet Oncol"},{"key":"506_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MNM.0000000000001310","volume":"42","author":"Y Ishiwata","year":"2021","unstructured":"Ishiwata Y, Kaneta T, Nawata S, et al. Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET\/computed tomography images of largest metastatic lymph node. Nucl Med Commun. 2021;42:86\u201392.","journal-title":"Nucl Med Commun"},{"key":"506_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.acra.2016.09.010","volume":"24","author":"AY Lee","year":"2017","unstructured":"Lee AY, Wisner DJ, Aminololama-Shakeri S, et al. Inter-reader variability in the use of BI-RADS descriptors for suspicious findings on diagnostic mammography: a multi-institution study of 10 academic radiologists. Acad Radiol. 2017;24:60\u20136.","journal-title":"Acad Radiol"},{"key":"506_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2214\/AJR.15.15049","volume":"206","author":"EU Ekpo","year":"2016","unstructured":"Ekpo EU, Ujong UP, Mello-Thoms C, McEntee MF. Assessment of Interradiologist agreement regarding mammographic breast density classification using the fifth edition of the BI-RADS atlas. AJR Am J Roentgenol. 2016;206:1119\u201323.","journal-title":"AJR Am J Roentgenol"},{"key":"506_CR36","doi-asserted-by":"publisher","first-page":"e0239975","DOI":"10.1371\/journal.pone.0239975","volume":"15","author":"AM H\u00f6tker","year":"2020","unstructured":"H\u00f6tker AM, Bl\u00fcthgen C, Rupp NJ, et al. Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: impact on diagnostic accuracy and inter-reader agreement. PLoS One. 2020;15:e0239975.","journal-title":"PLoS One"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.2214\/AJR.19.21913","volume":"214","author":"R Chung","year":"2020","unstructured":"Chung R, Rosenkrantz AB, Bennett GL, et al. Interreader concordance of the TI-RADS: impact of radiologist experience. AJR Am J Roentgenol. 2020;214:1152\u20137.","journal-title":"AJR Am J Roentgenol"},{"key":"506_CR38","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.5114\/pjr.2019.90090","volume":"84","author":"S Sevim","year":"2019","unstructured":"Sevim S, Dicle O, Gezer NS, et al. How high is the inter-observer reproducibility in the LIRADS reporting system? Pol J Radiol. 2019;84:e464\u20139.","journal-title":"Pol J Radiol"},{"key":"506_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2214\/AJR.14.13530","volume":"205","author":"LJ Grimm","year":"2015","unstructured":"Grimm LJ, Anderson AL, Baker JA, et al. Frequency of malignancy and imaging characteristics of probably benign lesions seen at breast MRI. AJR Am J Roentgenol. 2015;205:442\u20137.","journal-title":"AJR Am J Roentgenol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-022-00506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-022-00506-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-022-00506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:02:47Z","timestamp":1672012967000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-022-00506-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1186\/s40644-022-00506-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent forms were obtained.The datasets generated during and\/or analyzed during the current study are not publicly available due confidentiality but are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}